Page last updated: 2024-08-21

quinazolines and Benign Cerebellar Neoplasms

quinazolines has been researched along with Benign Cerebellar Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Alimova, I; Balakrishnan, I; Donson, A; Erlander, M; Foreman, NK; Fosmire, S; Joshi, M; Madhavan, K; Pierce, A; Ridinger, M; Sullivan, KD; Venkataraman, S; Veo, B; Vibhakar, R; Wang, D1
Bolin, S; Borgenvik, A; Bradner, JE; Cho, YJ; Persson, CU; Qi, J; Sundström, A; Swartling, FJ; Weishaupt, H; Weiss, WA1
Bebenek, M; Bryant, M; Diaz, RJ; Faria, C; Golbourn, B; Huang, A; Leadly, M; MacKenzie, D; Picard, D; Raynaud, D; Rutka, JT; Shih, D; Smith, CA; Taylor, MD1
Craveiro, RB; Dilloo, D; Ehrhardt, M; Goetz, B; Olschewski, M; Pietsch, T; Velz, J1
Abraham, J; Davare, MA; Giles, FJ; Hanes, MA; Keller, C; Kilcoyne, A; Lal, S; Nelon, LD; Ohshima-Hosoyama, S; Prajapati, SI; Rubin, BP1
Fujii, Y; Kuga, T; Matsuoka, T; Morikage, N; Nakayama, T1

Other Studies

6 other study(ies) available for quinazolines and Benign Cerebellar Neoplasms

ArticleYear
A novel PLK1 inhibitor onvansertib effectively sensitizes MYC-driven medulloblastoma to radiotherapy.
    Neuro-oncology, 2022, 03-12, Volume: 24, Issue:3

    Topics: Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms; Child; G2 Phase Cell Cycle Checkpoints; Humans; Medulloblastoma; Piperazines; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pyrazoles; Quinazolines

2022
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
    Oncogene, 2018, Volume: 37, Issue:21

    Topics: Azepines; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cerebellar Neoplasms; Cyclin-Dependent Kinase 2; Drug Synergism; Female; Humans; Medulloblastoma; Piperazines; Protein Kinase Inhibitors; Protein Stability; Proto-Oncogene Proteins c-myc; Pyrazoles; Pyridines; Quinazolines; Sequence Analysis, RNA; Signal Transduction; Triazoles; Xenograft Model Antitumor Assays

2018
Mechanism of action and therapeutic efficacy of Aurora kinase B inhibition in MYC overexpressing medulloblastoma.
    Oncotarget, 2015, Feb-20, Volume: 6, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Aurora Kinase B; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; Medulloblastoma; Mice, Nude; Molecular Targeted Therapy; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-myc; Quinazolines; Signal Transduction; Time Factors; Transfection; Tumor Burden; Up-Regulation; Xenograft Model Antitumor Assays

2015
The anti-neoplastic activity of Vandetanib against high-risk medulloblastoma variants is profoundly enhanced by additional PI3K inhibition.
    Oncotarget, 2017, Jul-18, Volume: 8, Issue:29

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cerebellar Neoplasms; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Humans; Indazoles; Medulloblastoma; Molecular Targeted Therapy; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Sulfonamides

2017
Preclinical testing of tandutinib in a transgenic medulloblastoma mouse model.
    Journal of pediatric hematology/oncology, 2012, Volume: 34, Issue:2

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Separation; Cerebellar Neoplasms; Disease Models, Animal; Flow Cytometry; Immunohistochemistry; Medulloblastoma; Mice; Mice, Transgenic; Piperazines; Quinazolines; Receptor, Platelet-Derived Growth Factor alpha; Reverse Transcriptase Polymerase Chain Reaction

2012
[A case of complete response in a primary lesion treated by gefitinib for two years after surgery of brain metastasis from lung cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:4

    Topics: Adenocarcinoma, Papillary; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Female; Gefitinib; Humans; Lung Neoplasms; Middle Aged; Quinazolines; Remission Induction; Vinblastine; Vinorelbine

2006